Predictions
Agfa Gevaert N.V.
Start price
Target price
Perf. (%)
€4.44
26.08.21
26.08.21
€5.50
26.08.22
26.08.22
-25.11%
27.08.22
27.08.22
Could be worthwhile Investment >10% per year
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€100.15
26.08.21
26.08.21
-
26.08.22
26.08.22
-2.84%
26.08.22
26.08.22
Valneva SE
Start price
Target price
Perf. (%)
€13.84
25.08.21
25.08.21
-
25.08.22
25.08.22
-32.23%
26.08.22
26.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.20
24.08.21
24.08.21
-
24.08.22
24.08.22
-24.81%
25.08.21
25.08.21
Probably not worthwhile Investment
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€126.20
24.08.21
24.08.21
-
24.08.22
24.08.22
-67.27%
24.08.22
24.08.22
Hexo Corp.
Start price
Target price
Perf. (%)
€31.22
23.08.21
23.08.21
-
23.08.22
23.08.22
-18.39%
14.09.21
14.09.21
Could be worthwhile Investment >10% per year
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€20.42
23.08.21
23.08.21
-
23.08.22
23.08.22
23.56%
14.09.21
14.09.21
Could be very worthwhile Investment >20% year
Innovative
Some uniques
Future proof or reliable business model
Endo International
Start price
Target price
Perf. (%)
€2.07
23.08.21
23.08.21
-
23.08.22
23.08.22
11.85%
14.09.21
14.09.21
Capable Management
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€22.67
23.08.21
23.08.21
€28.00
23.08.22
23.08.22
-0.88%
04.09.21
04.09.21
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
CASI Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.50
23.08.21
23.08.21
€10.00
23.08.22
23.08.22
7.20%
04.09.21
04.09.21
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Dependend from some customers or products
Abiomed Inc.
Start price
Target price
Perf. (%)
€299.10
21.08.21
21.08.21
€325.00
21.08.22
21.08.22
-10.60%
22.08.22
22.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.58
21.08.21
21.08.21
€220.00
21.08.22
21.08.22
-13.54%
08.01.22
08.01.22
Revenue growth >5% per year expected
Undervalued
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€123.30
17.08.21
17.08.21
-
17.08.22
17.08.22
-27.01%
12.01.22
12.01.22
ESSA Pharma Inc
Start price
Target price
Perf. (%)
€6.85
16.08.21
16.08.21
-
16.08.22
16.08.22
-0.73%
22.08.21
22.08.21
Risky Investment
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€15.31
16.08.21
16.08.21
-
16.08.22
16.08.22
-2.09%
22.08.21
22.08.21
Risky Investment
Coloplast A/S B
Start price
Target price
Perf. (%)
€151.65
13.08.21
13.08.21
€165.00
13.08.22
13.08.22
4.21%
30.12.21
30.12.21
Future proof or reliable business model
Known brand
Could be worthwhile Investment >10% per year
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€38.22
13.08.21
13.08.21
-
13.08.22
13.08.22
-3.95%
22.08.21
22.08.21
Risky Investment
NanoVibronix Inc.
Start price
Target price
Perf. (%)
€52.08
13.08.21
13.08.21
€20.00
13.08.22
13.08.22
-65.13%
08.01.22
08.01.22
Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
Allied Healthcare Products Inc
Start price
Target price
Perf. (%)
€12.20
10.08.21
10.08.21
-
10.08.22
10.08.22
-13.93%
13.08.21
13.08.21
Probably not worthwhile Investment
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€23.17
10.08.21
10.08.21
-
10.08.22
10.08.22
-11.87%
23.08.21
23.08.21
Could be very worthwhile Investment >20% year
Innovative
Some uniques
Future proof or reliable business model